Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations

por Cuesta, Hillary, El Menyawi, Ibrahim, Hubsch, Alphonse, Hoefferer, Liane, Mielke, Orell, Gabriel, Susie, Shebl, Amgad
Publicado 2022

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis...

por Shebl, Amgad, Gabriel, Susie, Van Dinther, Kristy, Hubsch, Alphonse, Lawo, John‐Philip, Hoefferer, Liane, Welsh, Susan
Publicado 2020